Inmolecule Nanotech, S.A.
MLINA | Euronext Growth
Overview
Corporate Details
- ISIN(s):
- ES0105908000
- LEI:
- 959800F0D3TQYVTXW034
- Country:
- Spain
- Address:
- N/A
- Website:
- https://www.inmolecule.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Inmolecule Nanotech, S.A. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Inmolecule Nanotech, S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Inmolecule Nanotech, S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Discovering novel gene editing tools from nature for curative genetic medicines.
United States of America
MGX
United States of America
MGX
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America
HYFT
United States of America
HYFT
Licenses patented helmet technology to reduce rotational impact injuries in sports and construction.
Sweden
MIPS
Sweden
MIPS
Japan
3636
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden
MODTX
Sweden
MODTX
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland
MOC
Poland
MOC
Clinical-stage biotech developing radiopharmaceuticals for oncology and therapies for rare diseases.
United States of America
MNPR
United States of America
MNPR
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
Ireland
MURA
Ireland
MURA
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom
N4P
United Kingdom
N4P
Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.
Poland
NNG
Poland
NNG